NuvoAir, a digital health start-up founded in Stockholm Sweden, focused on respiratory care. Breathing is everything. We breathe almost 1 billion times during our lifetime. While most of us take breathing for granted, for 1 out of every 10 people breathing can be a struggle.NuvoAir offers a care platform designed to support people with respiratory conditions achieve better outcomes, providers make the right clinical decisions and health plans achieve higher ROI.
NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. The NuvoAir Home platform blends connected devices with high-touch care coordination services to enable patients and their providers to proactively manage chronic conditions, resulting in better outcomes and lower costs. NuvoAir Home currently supports thousands of patients worldwide with COPD, cystic fibrosis, severe asthma, IPF, ALS, and muscular dystrophy. NuvoAir's decentralized clinical trial solution has been used in over 30 studies globally across all phases of drug development.
Total Funding: $17,002,000
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2C
Company Size: 26 to 50
Founded: 2016
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at NuvoAir
Senior Quality Engineer
Stockholm, Remote
Technical Recruiter
Boston, MA
Senior Finance Manager
Boston, MA
Manager, Engineering
Boston, MA
Frontend Developer
Boston, MA
